Understanding FDA’s Draft Guidance on Cancer Clinical Trial Eligibility Criteria: Performance Status
The FDA's draft guidance marks a significant step toward more inclusive and relevant cancer clinical trials. Aimed at industry stakeholders, IRBs, and clinical investigators, this document highlights the need to…